Ergomed: Ergomed strongly positioned for future growth in new
Permira completes acquisition of Ergomed for £703.1 millionThrough this partnership, Permira will support Dr. Miroslav Reljanović and the team in Ergomed’s next phase by accelerating the growth of the businessInvestment to focus on commercial expansion, technology and strategic M&A
Read full article »
Ergomed is an England-based clinical research company that provides services such as case processing and pharmacovigilance for the pharmaceutical industry.
Read more